Chapter 12 - RACHEL’S PATENT WASN’T A LOTTERY TICKETIndependent experts valued the old royalty claim.
Not $500 million.
Not fantasy wealth.
After offsets, expired patents, prior payments, and limitations issues:
Settlement value around $27 million.
Split through Rachel’s trust among Rachel, Gabriel, and me under revised agreements.
Substantial.
But the bigger reform was attribution.
Cross Biomedical had been erased from product history.
Whitmore Surgical restored Rachel as original inventor on archived materials where accurate.
Established an innovation-credit policy.
Funded independent review of inventor compensation.
Not charity.
Correction.
Rachel cried when she saw her name on the old sensor patent display.
Then said:
“I would’ve taken less money if they’d just stopped calling me crazy.”
May you like
That hurt more than the settlement.
Because disbelief had been part of the weapon.
